Home/Pipeline/LP-DF003

LP-DF003

Inherited Retinal Degenerative Diseases

Clinical DevelopmentActive

Key Facts

Indication
Inherited Retinal Degenerative Diseases
Phase
Clinical Development
Status
Active
Company

About 2-BBB Medicines

2-BBB Medicines is a private, clinical-stage biotech leveraging its proprietary G-Technology® liposomal platform to enhance drug delivery to the central nervous system and eyes. Originating from Leiden University, the company partners with pharma and biotech firms to develop improved therapies for oncology, neurology, and retinal diseases. Its strategy centers on de-risking development by applying its delivery technology to known compounds, with several partnered programs already in the clinic.

View full company profile